Hydroxychloroquine

Aus coViki
Wechseln zu: Navigation, Suche
GET 2020. Autophagy inhibition by chloroquine and hydroxychloroquine could adversely affect acute kidney injury and other organ injury in critically ill patients with COVID-19. Extract
  • GET ä. Use of Hydroxychloroquine and Chloroquine During the COVID-19 Pandemic: What Every Clinician Should Know Extract
  • GET ä. A Rush to Judgment? Rapid Reporting and Dissemination of Results and Its Consequences Regarding the Use of Hydroxychloroquine for COVID-19 Extract
GET 2020. Intracellular ABCB1 as a Possible Mechanism to Explain the Synergistic Effect of Hydroxychloroquine-Azithromycin Combination in COVID-19 Therapy. Extract
  • GET 2020. Of chloroquine and COVID-19 Extract
  • GET 2020. Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies Extract
  • GET 2020. A case report of serious haemolysis in a glucose-6-phosphate dehydrogenase-deficient COVID-19 patient receiving hydroxychloroquine. Extract
  • GET 2020. Neuropsychiatric adverse events of chloroquine: a real-world pharmacovigilance study using the FDA Adverse Event Reporting System (FAERS) database Extract
  • GET 2020. Update on use of chloroquine/hydroxychloroquine to treat coronavirus disease 2019 (COVID-19) Extract
  • GET 2020. Should chloroquine and hydroxychloroquine be used to treat COVID-19? A rapid review Extract
  • GET 2020. Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro Extract
  • GET 2020. Hydroxychloroquine use in the COVID-19 patient Extract
  • GET ä. In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Extract
  • GET ä. Could Chloroquine /Hydroxychloroquine Be Harmful in Coronavirus Disease 2019 (COVID-19) Treatment? Extract
  • GET ä. Is Hydroxychloroquine a Possible Postexposure Prophylaxis Drug to Limit the Transmission to Healthcare Workers Exposed to Coronavirus Disease 2019? Extract
  • GET ä. Towards Optimization of Hydroxychloroquine Dosing in Intensive Care Unit COVID-19 Patients Extract
  • GET ä. Chloroquine for SARS-CoV-2: Implications of Its Unique Pharmacokinetic and Safety Properties Extract
  • GET 2020. Safety considerations with chloroquine, hydroxychloroquine and azithromycin in the management of SARS-CoV-2 infection Extract
  • GET 2020. Shining a light on the evidence for hydroxychloroquine in SARS-CoV-2 Extract
  • GET ä. A Coronavirus Disease 2019 (COVID-19) Patient with Multifocal Pneumonia Treated with Hydroxychloroquine Extract
  • GET ä. Hydroxychloroquine in Covid-19: Does the end justify the means? Extract
  • GET 2020. Chloroquine and hydroxychloroquine in the treatment of COVID-19 with or without diabetes: A systematic search and a narrative review with a special reference to India and other developing countries Extract
  • GET 2020. Is GSK3beta a molecular target of chloroquine treatment against COVID-19? Extract
  • GET ä. Chiral switches of chloroquine and hydroxychloroquine: potential drugs to treat COVID-19 Extract
  • GET ä. Chloroquine for COVID-19 Infection Extract
  • GET 2020. Chloroquine and hydroxychloroquine in the context of COVID-19 Extract
  • GET 2020. Rheumotologitsts view on the use of hydroxychloroquine to treat COVID-19 Extract
  • GET ä. Chloroquine and hydroxychloroquine for COVID-19: implications for cardiac safety Extract
  • GET 2020. The Trial of Chloroquine in the Treatment of Corona Virus Disease 2019 COVID-19 and Its Research Progress in Forensic Toxicology Extract
  • GET ä. An algorithm for managing QT prolongation in coronavirus disease 2019 (COVID-19) patients treated with either chloroquine or hydroxychloroquine in conjunction with azithromycin: Possible benefits of intravenous lidocaine Extract
  • GET ä. Inpatient use of mobile continuous telemetry for COVID-19 patients treated with hydroxychloroquine and azithromycin Extract
  • GET 2020. SARS-CoV-2 infection in a patient on chronic hydroxychloroquine therapy: Implications for prophylaxis Extract
  • GET ä. Cardiovascular risks of hydroxychloroquine in treatment and prophylaxis of COVID-19 patients: A scientific statement from the Indian Heart Rhythm Society Extract
  • GET 2020. Improving the efficacy of Chloroquine and Hydroxychloroquine against SARS-CoV-2 may require Zinc additives - A better synergy for future COVID-19 clinical trials Extract
  • GET ä. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial Extract
  • GET ä. New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19? Extract
  • GET 2020. Chloroquine for the 2019 novel coronavirus SARS-CoV-2 Extract
  • GET ä. Chloroquine as prophylactic agent against COVID-19? Extract
  • GET ä. Aminoquinolines against coronavirus disease 2019 (COVID-19): chloroquine or hydroxychloroquine Extract
  • GET 2020. Chloroquine and hydroxychloroquine as available weapons to fight COVID-19 Extract
  • GET 2020. Chloroquine: Can it be a Novel Drug for COVID-19 Extract
  • GET ä. Does hydroxychloroquine combat COVID-19? A timeline of evidence Extract
  • GET ä. Inpatient Use of Ambulatory Telemetry Monitors for COVID-19 Patients Treated with Hydroxychloroquine and/or Azithromycin Extract
  • GET 2020. G6PD and chloroquine: Selecting the treatment against SARS?CoV?2? Extract
  • GET ä. Risk of QT Interval Prolongation Associated With Use of Hydroxychloroquine With or Without Concomitant Azithromycin Among Hospitalized Patients Testing Positive for Coronavirus Disease 2019 (COVID-19) Extract
  • GET ä. Assessment of QT Intervals in a Case Series of Patients With Coronavirus Disease 2019 (COVID-19) Infection Treated With Hydroxychloroquine Alone or in Combination With Azithromycin in an Intensive Care Unit Extract
  • GET 2020. Effect of High vs Low Doses of Chloroquine Diphosphate as Adjunctive Therapy for Patients Hospitalized With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection: A Randomized Clinical Trial Extract
  • GET 2020. Effect of High vs Low Doses of Chloroquine Diphosphate as Adjunctive Therapy for Patients Hospitalized With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection: A Randomized Clinical Trial Extract
  • GET ä. Inpatient use of mobile continuous telemetry for COVID-19 patients treated with hydroxychloroquine and azithromycin Extract
  • GET ä. Structural and molecular modelling studies reveal a new mechanism of action of chloroquine and hydroxychloroquine against SARS-CoV-2 infection Extract
  • GET ä. Hydroxychloroquine and ivermectin: a synergistic combination for COVID-19 chemoprophylaxis and/or treatment? Extract
  • GET ä. Considerations for Drug Interactions on QTc in Exploratory COVID-19 (Coronavirus Disease 2019) Treatment Extract
  • GET ä. COVID-19: a recommendation to examine the effect of hydroxychloroquine in preventing infection and progression Extract
  • GET ä. Combating COVID-19 with Chloroquine Extract
  • GET 2020. Challenges and cares to promote rational use of chloroquine and hydroxychloroquine in the management of coronavirus disease 2019 (COVID-19) pandemic: a timely review Extract
  • GET 2020. Behandling med 4-aminokinoliner vid covid-19 kan ge allvarliga biverkningar Extract
  • GET 2020. Regulators split on antimalarials for COVID-19 Extract
  • GET ä. Urgent Guidance for Navigating and Circumventing the QTc-Prolonging and Torsadogenic Potential of Possible Pharmacotherapies for Coronavirus Disease 19 (COVID-19) Extract
  • GET ä. Hydroxychloroquine in the management of critically ill patients with COVID-19: the need for an evidence base Extract
  • GET 2020. Excitement around hydroxychloroquine for treating COVID-19 causes challenges for rheumatology Extract
  • GET ä. Chloroquine or hydroxychloroquine for prophylaxis of COVID-19 Extract
  • GET ä. Hydroxychloroquine prophylaxis for COVID-19 contacts in India Extract
  • GET 2020. Review on the global epidemiological situation and the efficacy of chloroquine and hydroxychloroquine for the treatment of COVID-19 Extract
  • GET 2020. COVID-19, Chloroquine Repurposing, and Cardiac Safety Concern: Chirality Might Help Extract
  • GET 2020. Chloroquine in COVID-19: the evidence Extract
  • GET 2020. Chloroquine and COVID-19, where do we stand?? Extract
  • GET ä. No evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe COVID-19 infection Extract
  • GET ä. Chloroquine-induced QTc prolongation in COVID-19 patients Extract
  • GET 2020. In vitro testing of combined hydroxychloroquine and azithromycin on SARS-CoV-2 shows synergistic effect Extract
  • GET ä. Chloroquine paradox may cause more damage than help fight COVID-19 Extract
  • GET 2020. Potential use of hydroxychloroquine, ivermectin and azithromycin drugs in fighting COVID-19: trends, scope and relevance Extract
  • GET ä. Safety signals for QT prolongation or Torsades de Pointes associated with azithromycin with or without chloroquine or hydroxychloroquine Extract
  • GET ä. Review: Hydroxychloroquine and Chloroquine for Treatment of SARS-CoV-2 (COVID-19) Extract
  • GET 2020. Coalition: Advocacy for prospective clinical trials to test the post-exposure potential of hydroxychloroquine against COVID-19 Extract
  • GET ä. Driving forces for COVID-19 clinical trials using chloroquine: the need to choose the right research questions and outcomes Extract
  • GET 2020. An independent appraisal and re-analysis of hydroxychloroquine treatment trial for COVID-19 Extract
  • GET 2020. COVID-19 and Chloroquine/Hydroxychloroquine: is there Ophthalmological Concern? Extract
GET ä. Chloroquine and Hydroxychloroquine Retinal Toxicity Consideration in the Treatment of COVID-19 Extract
  • GET 2020. Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six-day follow up: A pilot observational study Extract
  • GET ä. Repurposing antimalarials and other drugs for COVID-19 Extract
  • GET ä. Continuous hydroxychloroquine or colchicine therapy does not prevent infection with SARS-CoV-2: Insights from a large healthcare database analysis Extract
  • GET 2020. Response to: Optimizing Hydroxychloroquine Dosing for Patients With COVID-19: An Integrative Modeling Approach for Effective Drug Repurposing: Quantitative Clinical Pharmacology Input to SARS-CoV-2 Therapeutics Should Be Based on Robust Data Extract
  • GET 2020. Virological and clinical cure in COVID-19 patients treated with hydroxychloroquine: A systematic review and meta-analysis Extract
  • GET 2020. A systematic review on the efficacy and safety of chloroquine for the treatment of COVID-19 Extract
  • GET 2020. The Risks of Prescribing Hydroxychloroquine for Treatment of COVID-19-First, Do No Harm Extract
  • GET 2020. Treating COVID-19 with Chloroquine Extract
  • GET 2020. The friendly use of chloroquine in the COVID-19 disease: a warning for the G6PD-deficient males and for the unaware carriers of pathogenic alterations of the G6PD gene Extract
  • GET ä. Observational Study of Hydroxychloroquine in Hospitalized Patients with Covid-19 Extract
  • GET 2020. Chloroquine and Hydroxychloroquine in the Era of SARS - CoV2: Caution on Their Cardiac Toxicity Extract
  • GET 2008. Ferrocene Conjugates of Chloroquine and other Antimalarials: the Development of Ferroquine, a New Antimalarial Extract
  • GET 2020. Expert consensus on chloroquine phosphate for the treatment of novel coronavirus pneumonia Extract
GET ä. Chloroquine reduces Th17 cell differentiation by stimulating T-bet expression in T cells Extract
  • GET 2020. Chloroquin gegen Corona? Extract
  • GET 2020. Safety concerns with higher dosage chloroquine in COVID-19 patients Extract
  • GET 2020. Antimalarial use in COVID-19 patients requires close monitoring Extract
  • GET 2020. Epidemie de coronavirus et polemique sur la chloroquine Extract
  • GET 2020. Covid-19, dans les brouillards francais de l'hydroxychloroquine Extract
  • GET 2020. Covid-19, dans les brouillards de l'hydroxychloroquine (2) Extract
  • GET ä. Acute hemolysis by hydroxycloroquine was observed in G6PD-deficient patient with severe COVD-19 related lung injury Extract
GET 2020. Blocking drug-induced autophagy with chloroquine in HCT-116 colon cancer cells enhances DC maturation and T cell responses induced by tumor cell lysate Extract
GET ä. Chloroquine-induced torsades de pointes in a patient with coronavirus disease 2019 Extract
  • GET ä. Chloroquine as a prophylactic agent against COVID-19? Extract
  • GET ä. Ventricular arrhythmia risk due to chloroquine / hydroxychloroquine treatment for COVID-19: Should it be given Extract
GET ä. Excessive lysosomal ion-trapping of hydroxychloroquine and azithromycin Extract
  • GET 2020. Hydroxychloroquine as an aerosol might markedly reduce and even prevent severe clinical symptoms after SARS-CoV-2 infection Extract
  • GET ä. ...surveillance ophtalmologique ...hydroxychloroquine e... Extract
  • GET 2020. Does zinc supplementation enhance the clinical efficacy of chloroquine/hydroxychloroquine to win todays battle against COVID-19? Extract
  • GET ä. Uso de antipaludicos (antimalarials)... Extract
  • GET 2014. Chloroquine interferes with dengue?2 virus replication in U937 cells Extract
  • GET ä. An evaluation of co-use of chloroquine or hydroxychloroquine plus azithromycin on cardiac outcomes: A pharmacoepidemiological study to inform use during the COVID19 pandemic Extract
  • GET ä. Hydroxychloroquine: small effects in mild disease Extract
  • GET ä. ?Off-label? use of hydroxychloroquine, azithromycin, lopinavir-ritonavir and chloroquine in COVID-19: A survey of cardiac adverse drug reactions by the French Network of Pharmacovigilance Centers Extract
  • GET ä. Hydroxychloroquine and ?off-label? utilization in the treatment of oral conditions Extract
GET 2017. Targeting endosomal acidification by chloroquine analogs as a promising strategy for the treatment of emerging viral diseases Extract
  • GET ä. Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France Extract
  • GET ä. Therapeutic use of chloroquine and hydroxychloroquine in COVID-19 and other viral infections: A narrative review Extract
  • GET 2020. Hidroxicloroquina. Mensajes desde la cardiologia en tiempos de pandemia por coronavirus. Extract
  • GET 2020. [Pharmacological characteristics of chloroquine and suggestions for its use in treatment of coronavirus disease 2019 (COVID-19)]. Extract
  • GET 2020. [Expert consensus on chloroquine phosphate for the treatment of novel coronavirus pneumonia]. Extract
  • GET 2020. Mass intake of hydroxychloroquine or chloroquine in the present context of the Covid-19 outbreak: Possible consequences in endemic malaria settings. Extract
  • GET 2020. Doubtful precipitation of hemolysis by hydroxychloroquine in glucose-6-phosphate dehydrogenase deficient patient with COVID-19 infection. Extract
  • GET 2020. Risk of using hydroxychloroquine as a treatment of COVID-19. Extract
  • GET 2020. Hydroxychloroquine against COVID-19: A critical appraisal of the existing evidence. Extract
  • GET 2020. Chloroquine and the potential adverse outcome in undiagnosed G6PD-deficient cases infected with COVID-19. Extract
  • GET 2020. Connecting hydroxychloroquine in vitro antiviral activity to in vivo concentration for prediction of antiviral effect: a critical step in treating COVID-19 patients. Extract
  • GET 2020. Chloroquine and hydroxychloroquine to treat COVID-19: between hope and caution. Extract
  • GET 2020. Chloroquine and COVID-19 - a potential game changer? Extract


  • GET 2020. To consider or not antimalarials as a prophylactic intervention in the SARS-CoV-2 (COVID-19) pandemic. Extract
  • GET 2020. Hydroxychloroquine reduces the risk of covid-19 in patients with rheumatic diseases: myth or reality? Extract
  • GET 2020. Is there a future for hydroxychloroquine/chloroquine in prevention of SARS-CoV-2 infection (COVID-19)? Extract


  • GET 2020. Can hydroxychloroquine protect patients with rheumatic diseases from COVID-19? Response to: 'Does hydroxychloroquine prevent the transmission of COVID-19?' by Heldwein and Calado and 'SLE, hydroxychloroquine and no SLE patients with COVID-19: a comment' by Joob and Wiwanitkit. Extract
  • GET 2020. Does hydroxychloroquine prevent the transmission of COVID-19? Extract
  • GET 2020. Festina lente: hydroxychloroquine, COVID-19 and the role of the rheumatologist. Extract
  • GET 2020. Response to 'Is there a future for hydroxychloroquine/chloroquine in prevention of SARS-CoV-2 infection (COVID-19)?' by Moiseev et al. Extract


  • GET 2020. Dose Optimization of Hydroxychloroquine for COVID-19: Do Blood Concentrations Matter? Extract
  • GET 2020. Association of Hydroxychloroquine with QTc Interval in Patients with COVID-19. Extract
  • GET 2020. Considerations for Drug Interactions on QTc in Exploratory COVID-19 Treatment. Extract
  • GET 2020. Acute chloroquine poisoning: A comprehensive experimental toxicology assessment of the role of diazepam. Extract
  • GET 2020. Use of Chloroquine and Hydroxychloroquine in COVID-19 and Cardiovascular Implications: Understanding Safety Discrepancies to Improve Interpretation and Design of Clinical Trials. Extract
  • GET 2020. Effect of Chloroquine, Hydroxychloroquine, and Azithromycin on the Corrected QT Interval in Patients With SARS-CoV-2 Infection. Extract
  • GET 2020. Lack of efficacy of hydroxychloroquine in covid-19. Extract
  • GET 2020. Covid-19: Hydroxychloroquine was ineffective as postexposure prophylaxis, study finds. Extract
  • GET 2020. Covid-19: 146 researchers raise concerns over chloroquine study that halted WHO trial. Extract
  • GET 2020. Chloroquine and hydroxychloroquine in covid-19. Extract
  • GET 2020. Docking study of Chloroquine and Hydroxychloroquine interaction with SARS-CoV-2 spike glycoprotein-An in silico insight into the comparative efficacy of repurposing antiviral drugs. Extract
  • GET 2020. Efficacy, safety and cost-effectiveness of hydroxychloroquine in children with COVID-19: A call for evidence. Extract
  • GET 2020. Rationale of a loading dose initiation for hydroxychloroquine treatment in COVID-19 infection in the DisCoVeRy trial. Extract
  • GET 2020. Failure of hydroxychloroquine pre-exposure prophylaxis in COVID-19 infection? A case report. Extract


  • GET 2020. An open label cluster randomized controlled trial of chloroquine, hydroxychloroquine or only supportive care in patients admitted with moderate to severe COVID-19 (ARCHAIC) - Protocol publication. Extract
  • GET 2020. [A szerzett hosszu-QT-szindroma veszelye a koronavirus-jarvany idejen. Fokuszban a hidroxiklorokin] Extract
  • GET 2020. Potential negative effects of the free use of chloroquine to manage COVID-19 in Colombia. Extract
  • GET 2020. Hydroxychloroquine and Azithromycin to Treat Patients With COVID-19: Both Friends and Foes? Extract
  • GET 2020. In-silico strategies for probing chloroquine based inhibitors against SARS-CoV-2. Extract
  • GET 2020. Hydroxychloroquine and covid-19. Extract
  • GET 2020. Advances in the use of chloroquine and hydroxychloroquine for the treatment of COVID-19. Extract
  • GET 2020. The QT interval in patients with COVID-19 treated with hydroxychloroquine and azithromycin. Extract



  • GET 2020. Why G6PD Deficiency Should Be Screened Before COVID-19 Treatment With Hydroxychloroquine? Extract
  • GET 2020. HyPE study: hydroxychloroquine prophylaxis-related adverse events' analysis among healthcare workers during COVID-19 pandemic: a rising public health concern. Extract
  • GET 2020. Hydroxychloroquine for the Prevention of Covid-19 - Searching for Evidence. Extract
  • GET 2020. A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19. Extract
  • GET 2020. Fatal arrhythmias: Another reason why doctors remain cautious about chloroquine/hydroxychloroquine for treating COVID-19. Extract
  • GET 2020. A systematic review of the prophylactic role of chloroquine and hydroxychloroquine in coronavirus disease-19 (COVID-19). Extract
  • GET 2020. Hydroxychloroquine for Covid-19 - When the pandemic runs faster than research. Extract
  • GET 2020. Arrhythmic profile and 24-hour QT interval variability in COVID-19 patients treated with hydroxychloroquine and azithromycin. Extract
  • GET 2020. A review on possible modes of action of chloroquine/hydroxychloroquine: repurposing against SAR-CoV-2 (COVID-19) pandemic. Extract
  • GET 2020. Synergistic antiviral effect of hydroxychloroquine and azithromycin in combination against SARS-CoV-2: What molecular dynamics studies of virus-host interactions reveal. Extract
  • GET 2020. Hydroxychloroquine pharmacokinetic in COVID-19 critically ill patients: an observational cohort study. Extract
  • GET 2020. Hydroxychloroquine and azithromycin as a treatment of COVID-19. Extract
  • GET 2020. The ICMR bulletin on targeted hydroxychloroquine prophylaxis for Covid-19: Need to interpret with caution. Extract
  • GET 2020. Outpatient hydroxychloroquine prescribing at a large academic health system during the COVID-19 pandemic. Extract
  • GET 2020. COVID-19 treatments, QT interval, and arrhythmic risk: The need for an international registry on arrhythmias. Extract
  • GET 2020. QT interval prolongation and torsade de pointes in patients with COVID-19 treated with hydroxychloroquine/azithromycin. Extract
  • GET 2020. QT prolongation, torsades de pointes, and sudden death with short courses of chloroquine or hydroxychloroquine as used in COVID-19: A systematic review. Extract
  • GET 2020. Behavior of the PR Interval with Increasing Heart Rate in Patients with COVID-19. Extract
  • GET 2020. [Brug af hydroxychloroquin til COVID-19]. Extract
  • GET 2020. [Lack of clinical evidence for the use of hydroxychloroquine to treat SARS-CoV-2 infection]. Extract
  • GET 2020. [A pilot study of hydroxychloroquine in treatment of patients with moderate COVID-19]. Extract
  • GET 2020. Adverse drug reactions of hydroxychloroquine: Analysis of French pre-pandemic SARS-CoV2 pharmacovigilance data. Extract
  • GET 2020. COVID-19, dans les brouillards de l'hydroxychloroquine (4). Extract
  • GET 2020. Covid-19, dans les brouillards de l'hydroxychloroquine (3). Extract
  • GET 2020. Acute generalized exanthematous pustulosis induced by hydroxychloroquine prescribed for COVID-19. Extract
  • GET 2020. Hydroxychloroquine in Patients with Rheumatic Disease Complicated by COVID-19: Clarifying Target Exposures and the Need for Clinical Trials. Extract
  • GET 2020. Evidence of Protective Effect of Hydroxychloroquine on COVID-19. Extract
  • GET 2020. The rediscovery of hydroxychloroquine in allergic diseases in the COVID-19 era. Extract
  • GET 2020. Experience With Hydroxychloroquine and Azithromycin in the Coronavirus Disease 2019 Pandemic: Implications for QT Interval Monitoring. Extract
  • GET 2020. Chloroquine or Hydroxychloroquine for COVID-19: Is Cardiotoxicity a Concern? Extract
  • GET 2020. Hydroxychloroquine as prophylaxis or treatment for COVID-19: What does the evidence say? Extract
  • GET 2020. Comment on: COVID-19: a recommendation to examine the effect of hydroxychloroquine in preventing infection and progression. Extract
  • GET 2020. Hydroxychloroquine effects on psoriasis: A systematic review and a cautionary note for COVID-19 treatment. Extract
  • GET 2020. Dermatologic manifestations of hydroxychloroquine therapy: a closer look at the nails. Extract
  • GET 2020. Can hydroxychloroquine be useful in the prevention of COVID-19? An Italian survey in dermatologic and rheumatologic patients already under treatment. Extract
  • GET 2020. Response to: "Risks of hydroxychloroquine use for COVID-19 prophylaxis". Extract
  • GET 2020. COVID-19, Clinical Trials and QT-Prolonging Prophylactic Therapy in Healthy Subjects: First, Do No Harm. Extract
  • GET 2020. Antihyperglycemic properties of hydroxychloroquine in patients with diabetes: Risks and benefits at the time of COVID-19 pandemic. Extract
  • GET 2020. Experience of short-term hydroxychloroquine and azithromycin in COVID-19 patients and effect on QTc trend. Extract
  • GET 2020. COVID-19 infection also occurs in patients taking hydroxychloroquine. Extract
  • GET 2020. Cardiovascular Safety of Potential Drugs for the Treatment of Coronavirus Disease 2019. Extract
GET 2020. Glucose-6-phosphate dehydrogenase deficiency-associated hemolysis and methemoglobinemia in a COVID-19 patient treated with chloroquine. Extract
  • GET 2020. A Rapid Systematic Review of Clinical Trials Utilizing Chloroquine and Hydroxychloroquine as a Treatment for COVID-19. Extract
  • GET 2020. Revisiting hydroxychloroquine and chloroquine for patients with chronic immunity-mediated inflammatory rheumatic diseases. Extract
  • GET 2020. Hydroxychloroquine as antiviral prophylaxis for exposed caregivers to Covid-19: An urgent appraisal is needed. Extract
  • GET 2020. COVID-19 and Chloroquine/Hydroxychloroquine: Is There Ophthalmological Concern? Extract
  • GET 2020. Lack of viral clearance by the combination of hydroxychloroquine and azithromycin or lopinavir and ritonavir in SARS-CoV-2-related acute respiratory distress syndrome. Extract
  • GET 2020. Should Clinicians Use Chloroquine or Hydroxychloroquine Alone or in Combination With Azithromycin for the Prophylaxis or Treatment of COVID-19? Extract
  • GET 2020. Case Report: Right Bundle Brunch Block and QTc Prolongation in a Patient with Novel Coronavirus Disease (COVID-19) Treated with Hydroxychloroquine. Extract
  • GET 2020. Case Report: Hepatotoxicity Associated with the Use of Hydroxychloroquine in a Patient with COVID-19. Extract
  • GET 2020. Measurement of hydroxychloroquine in blood from SLE patients using LC-HRMS-evaluation of whole blood, plasma, and serum as sample matrices. Extract
  • GET 2020. Response to the editorial "COVID-19 in patients with cardiovascular diseases": Covid-19 treatment with hydroxychloroquine or chloroquine and azithromycin: A potential risk of Torsades de Pointes. Extract
  • GET 2020. The status surrounding chloroquine and other drugs as potential anti-infective agents for COVID-19. Extract
  • GET 2020. Impact of disease on plasma and lung exposure of chloroquine, hydroxy-chloroquine and azithromycin: application of PBPK modelling. Extract
  • GET 2020. Review on the clinical pharmacology of hydroxychloroquine sulfate for the treatment of COVID-19. Extract
  • GET 2020. Antimalarial use and arrhythmias in COVID-19 and rheumatic patients: a matter of dose and inflammation? Extract
  • GET 2020. Response to: 'Antimalarial use and arrhythmias in COVID-19 and rheumatic patients: a matter of dose and inflammation?' by Erre et al. Extract
  • GET 2020. To consider or not antimalarials as a prophylactic intervention in the SARS-CoV-2 (Covid-19) pandemic. Extract
  • GET 2020. Does Adding of Hydroxychloroquine to the Standard Care Provide any Benefit in Reducing the Mortality among COVID-19 Patients?: a Systematic Review. Extract
  • GET 2020. Smooth or Risky Revisit of an Old Malaria Drug for COVID-19? Extract
  • GET 2020. Hydroxychloroquine or Chloroquine for Treatment or Prophylaxis of COVID-19: A Living Systematic Review. Extract
GET 2020. Intentional Hydroxychloroquine Overdose Treated with High-Dose Diazepam: an Increasing Concern in the COVID-19 Pandemic. Extract
  • GET 2020. Recommendations for the measurement of the QT interval during the use of drugs for COVID-19 infection treatment. Updatable in accordance with the availability of new evidence. Extract
  • GET 2020. Hydroxychloroquine and azithromycin as potential treatments for COVID-19; clinical status impacts the outcome. Extract
  • GET 2020. Conduction abnormalities in hydroxychloroquine add on therapy to lopinavir/ritonavir in COVID-19. Extract
  • GET 2020. Hydroxychloroquine/ chloroquine as a treatment choice or prophylaxis for Covid-19 at the primary care level in developing countries: A Primum non Nocere dilemma. Extract
  • GET 2020. Drug reaction with eosinophilia and systemic symptoms syndrome to hydroxychloroquine, an old drug in the spotlight in the COVID-19 era. Extract
  • GET 2020. Acute generalized exanthematous pustulosis after COVID-19 treatment with hydroxychloroquine. Extract
  • GET 2020. Generalized pustular figurate erythema: A newly delineated severe cutaneous drug reaction linked with hydroxychloroquine. Extract
  • GET 2020. Efficacy of chloroquine and hydroxychloroquine in the treatment of COVID-19. Extract
  • GET 2020. QTc evaluation in COVID-19 patients treated with chloroquine/hydroxychloroquine. Extract
  • GET 2020. [Pharmacovigilance study on drug-induced cardiac injury during treatment of COVID-19]. Extract
  • GET 2020. Hydroxychloroquine: A Familiar Agent to Combat the Pandemic of COVID-19. Extract
  • GET 2020. SARS-CoV-2 and the Use of Chloroquine as an Antiviral Treatment. Extract
  • GET 2020. The Role of Hydroxychloroquine in Coronavirus Disease 2019. A Versatile Tool at the Service of Humanity. Extract
  • GET 2020. Rethinking the role of hydroxychloroquine in the treatment of COVID-19. Extract
  • GET 2020. A New Drug-Drug Interaction Between Hydroxychloroquine and Metformin? A Signal Detection Study. Extract
  • GET 2020. COVID-19 infection and treatment with hydroxychloroquine cause severe haemolysis crisis in a patient with glucose-6-phosphate dehydrogenase deficiency. Extract
  • GET 2020. "Hydroxychloroquine in patients with COVID-19: A Systematic Review and meta-analysis." Extract
  • GET 2020. Incidence and Determinants of QT Interval Prolongation in COVID-19 Patients Treated with Hydroxychloroquine and Azithromycin. Extract
  • GET 2020. Hydroxychloroquine and ritonavir for COVID-19 infection: a possible synergic toxicity for retinal pigmented epithelium. Extract
  • GET 2020. Association of Treatment With Hydroxychloroquine or Azithromycin With In-Hospital Mortality in Patients With COVID-19 in New York State. Extract
  • GET 2020. Chloroquine or hydroxychloroquine for COVID-19: why might they be hazardous? Extract
  • GET 2020. A systematic review on use of aminoquinolines for the therapeutic management of COVID-19: Efficacy, safety and clinical trials. Extract
  • GET 2020. Pharmacist's perspective on HCQ treatment of COVID-19. Extract
  • GET 2020. In vitro activity of lopinavir/ritonavir and hydroxychloroquine against severe acute respiratory syndrome coronavirus 2 at concentrations achievable by usual doses. Extract
  • GET 2020. Chloroquine-induced QTc prolongation in COVID-19 patients. Extract
  • GET 2020. Hidroxicloroquina en el tratamiento del COVID-19: como utilizarla a la espera de evidencia cientifica concluyente. Extract
  • GET 2020. The possible mechanisms of action of 4-aminoquinolines (chloroquine/hydroxychloroquine) against Sars-Cov-2 infection (COVID-19): A role for iron homeostasis? Extract
  • GET 2020. Chloroquine and hydroxychloroquine for COVID-19: A word of caution. Extract
  • GET 2020. Evidencia viva como respuesta a las controversias en el uso de antimalaricos en COVID-19. Extract
  • GET 2020. Perspectives on repositioning chloroquine and hydroxychloroquine for the treatment of Covid-19. Extract
  • GET 2020. Chloroquine dosage regimens in patients with COVID-19: Safety risks and optimization using simulations. Extract
  • GET 2020. Low dose of hydroxychloroquine reduces fatality of critically ill patients with COVID-19. Extract
  • GET 2020. Update Alert: Should Clinicians Use Chloroquine or Hydroxychloroquine Alone or in Combination With Azithromycin for the Prophylaxis or Treatment of COVID-19? Living Practice Points From the American College of Physicians. Extract
  • GET 2020. Hydroxychloroquine-azithromycin for COVID-19 - Warranted or dangerous? Extract
  • GET 2020. Malaria prophylaxis approach during COVID-19 pandemic. Extract
  • GET 2020. Chloroquine and hydroxychloroquine in the management of COVID-19: Much kerfuffle but little evidence. Extract
  • GET 2020. Chloroquine and hydroxychloroquine during pregnancy: What do we know? Extract
  • GET 2020. Chloroquine, hydroxychloroquine and COVID-19. Extract
  • GET 2020. A Double-Edged Sword-Cardiovascular Concerns of Potential Anti-COVID-19 Drugs. Extract
  • GET 2020. Acute generalized exanthematous pustulosis induced by empiric hydroxychloroquine for presumed COVID-19. Extract
  • GET 2020. Clinical efficacy of hydroxychloroquine in patients with covid-19 pneumonia who require oxygen: observational comparative study using routine care data. Extract
  • GET 2020. Chloroquine cardiac effects and toxicity.A short update. Extract
  • GET 2020. Compassionate use of hydroxychloroquine in clinical practice for patients with mild to severe Covid-19 in a French university hospital. Extract
  • GET 2020. Hydroxychloroquine for covid-19: the end of the line? Extract
  • GET 2020. QT interval prolongation under hydroxychloroquine/ azithromycin association for inpatients with SARS-CoV-2 lower respiratory tract infection. Extract
  • GET 2020. Facts and myths: Efficacies of repurposing chloroquine and hydroxychloroquine for the treatment of COVID-19. Extract
  • GET 2020. Hydroxychloroquine, COVID-19 and diabetes. Why it is a different story. Extract
  • GET 2020. Comment on "Smooth or Risky Revisit of an Old Malaria Drug for COVID-19?" Extract
  • GET 2020. A Case of Breakthrough COVID-19 during Hydroxychloroquine Maintenance. Extract
  • GET 2020. Clearance of chloroquine and hydroxychloroquine by the Seraph(R) 100 Microbind(R) Affinity blood filter - approved for the treatment of COVID-19 patients. Extract
GET 2020. Screening of Chloroquine, Hydroxychloroquine and its derivatives for their binding affinity to multiple SARS-CoV-2 protein drug targets. Extract
GET 2020. Cutaneous side effects of hydroxychloroquine in health care workers in a COVID referral hospital - implications for clinical practice. Extract
  • GET 2020. Chloroquine in controlling biological infections. Extract
  • GET 2020. Chloroquine and Hydroxychloroquine for the Prevention or Treatment of COVID-19 in Africa: Caution for Inappropriate Off-label Use in Healthcare Settings. Extract
  • GET 2020. Hydroxychloroquine as Prophylaxis for Coronavirus SARS-CoV-2 Infection: Review of the Ongoing Clinical Trials. Extract
  • GET 2020. Psychiatric adverse events with hydroxychloroquine during COVID-19 pandemic. Extract
  • GET 2020. Hydroxychloroquine in patients with mainly mild to moderate coronavirus disease 2019: open label, randomised controlled trial. Extract
  • GET 2020. Clinical efficacy of hydroxychloroquine in patients with covid-19 pneumonia who require oxygen: observational comparative study using routine care data. Extract
  • GET 2020. COVID-19 and (hydroxy)chloroquine-azithromycin combination: Should we take the risk for our patients? Extract
  • GET 2020. Novel Approach for Low-Dose Pulmonary Delivery of Hydroxychloroquine in COVID-19. Extract
  • GET 2020. Hydroxychloroquine-based treatments in the CoViD-19 pandemic. Extract
  • GET 2020. Chloroquine and hydroxychloroquine repositioning in times of COVID-19 pandemics, all that glitters is not gold. Extract
  • GET 2020. Chloroquine and COVID-19: A western medical and scientific drift? Extract
  • GET 2020. Effects of Hydroxychloroquine Treatment on QT Interval. Extract
GET 2020. Covid-19: Oxford team begins vaccine trials in Brazil and South Africa to determine efficacy. Extract
least regulated zones biggest negroe populations
  • GET 2020. Model informed dosing of Hydroxycholoroquine in COVID-19 patients: Learnings from the recent experience, remaining uncertainties and Gaps. Extract
  • GET 2020. The many mechanisms of action of Chloroquine: to use or not to use (in COVID-19) that is the question. Extract
  • GET 2020. An Updated Systematic Review of the Therapeutic Role of Hydroxychloroquine in Coronavirus Disease-19 (COVID-19). Extract
  • GET 2020. Hydroxychloroquine in COVID-19 patients: what still needs to be known about the kinetics. Extract
  • GET 2020. Clinical evidence for repurposing chloroquine and hydroxychloroquine as antiviral agents: a systematic review. Extract
  • GET 2020. Safety considerations for chloroquine and hydroxychloroquine in the treatment of COVID-19. Extract
  • GET 2020. Chloroquine for COVID-19: rationale, facts, hopes. Extract
  • GET 2020. Hydroxychloroquine for Treatment of SARS-CoV-2 Infection? Improving Our Confidence in a Model-Based Approach to Dose Selection. Extract
  • GET 2020. Do we have enough evidence to use chloroquine/hydroxychloroquine as a public health panacea for COVID-19? Extract
  • GET 2020. Safety considerations with chloroquine, hydroxychloroquine and azithromycin in the management of SARS-CoV-2 infection. Extract
  • GET 2020. Optimizing Hydroxychloroquine Dosing for Patients With COVID-19: An Integrative Modeling Approach for Effective Drug Repurposing. Extract
  • GET 2020. Hydroxychloroquine and chloroquine in COVID-19: should they be used as standard therapy? Extract
  • GET 2020. Response to "Quantitative Clinical Pharmacology INPUT to SARS-CoV-2 Therapeutics Should be Based on Robust Data": Data-Driven Dosing Recommendations are Urgently Needed for Hydroxychloroquine in COVID-19 Patients: Response to Letter to the Editor. Extract
  • GET 2020. Finding the Dose for Hydroxychloroquine Prophylaxis for COVID-19: The Desperate Search for Effectiveness. Extract
  • GET 2020. Chloroquine Dosing Recommendations for Pediatric COVID-19 Supported by Modeling and Simulation. Extract
  • GET 2020. Does Adding of Hydroxychloroquine to the Standard Care Provide any Benefit in Reducing the Mortality among COVID-19 Patients?: a Systematic Review. Extract
  • GET 2020. Assessing the risk of seizures with chloroquine or hydroxychloroquine therapy for COVID-19 in persons with epilepsy. Extract
  • GET 2020. Clinical Implications of Chloroquine and Hydroxychloroquine Ototoxicity for COVID-19 Treatment: A Mini-Review. Extract
  • GET 2020. COVID-19 and hydroxychloroquine: Is the wonder drug failing? Extract
  • GET 2020. A Pharmacovigilance Study of Hydroxychloroquine Cardiac Safety Profile: Potential Implication in COVID-19 Mitigation. Extract
  • GET 2020. Outcomes of 3,737 COVID-19 patients treated with hydroxychloroquine/azithromycin and other regimens in Marseille, France: A retrospective analysis. Extract
  • GET 2020. Does pandemic justify the use of hydroxychloroquine for treatment and prevention of COVID-19 in India? Extract
  • GET 2020. Caution Needed on the Use of Chloroquine and Hydroxychloroquine for Coronavirus Disease 2019. Extract
  • GET 2020. When there is a pandemic there is no time to waste: should we have hydroxychloroquine in our armoury against COVID-19 infected patients? Extract
  • GET 2020. Systematic review of registered trials of Hydroxychloroquine prophylaxis for COVID-19 health-care workers at the first third of 2020. Extract
  • GET 2020. Living evidence in response to controversies about the use of antimalarials in COVID-19. Extract
  • GET 2020. Safety use of hydroxychloroquine and its combination with azithromycin in the context of Sars-CoV-2 outbreak: Clinical experience in a Belgian tertiary center. Extract
  • GET 2020. Role of antimalarials in COVID-19: observational data from a cohort of rheumatic patients. Extract
  • GET 2020. Protocolo para la prevencion de arritmias ventriculares debido al tratamiento en pacientes con COVID-19. Extract
  • GET 2020. The effect of potential therapeutic agents on QT interval in patients with COVID-19 Infection: The importance of close monitoring and correction of electrolytes. Extract
Meine Werkzeuge
Namensräume
Varianten
Aktionen
Navigation
Werkzeuge